Preliminary scientific tests point out conolidine may inhibit unique ion channels, minimizing neuronal excitability and restricting pain indicators. This system is especially appropriate in neuropathic suffering, wherever irregular signaling causes persistent soreness. Furthermore, conolidine seems to impact G protein-coupled receptor (GPCR) pathwa